Nothing Special   »   [go: up one dir, main page]

AU5516590A - Dehydrocholecalciferol derivatives - Google Patents

Dehydrocholecalciferol derivatives

Info

Publication number
AU5516590A
AU5516590A AU55165/90A AU5516590A AU5516590A AU 5516590 A AU5516590 A AU 5516590A AU 55165/90 A AU55165/90 A AU 55165/90A AU 5516590 A AU5516590 A AU 5516590A AU 5516590 A AU5516590 A AU 5516590A
Authority
AU
Australia
Prior art keywords
dehydrocholecalciferol
derivatives
deuterium
new
dehydrocholecalciferal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU55165/90A
Other versions
AU636609B2 (en
Inventor
Enrico Guiseppe Baggiolini
Bernard Michael Hennessy
Shian-Jan Shiuey
Gary Arthur Truitt
Milan Radoje Uskokovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU5516590A publication Critical patent/AU5516590A/en
Application granted granted Critical
Publication of AU636609B2 publication Critical patent/AU636609B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

The use of dehydrocholecalciferal derivs. of formula (I) to make pharmaceuticals for treating diseases of the sebaceous glands is new. (Where R = H or OH; A = CC, (E)-CH=CH or CH2CH2; R'' = H or, where A = C=C, it can also be deuterium). (I) are new cpds. where R'' = deuterium.
AU55165/90A 1989-05-18 1990-05-17 Dehydrocholecalciferol derivatives Ceased AU636609B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35371689A 1989-05-18 1989-05-18
US353716 1989-05-18

Publications (2)

Publication Number Publication Date
AU5516590A true AU5516590A (en) 1990-11-22
AU636609B2 AU636609B2 (en) 1993-05-06

Family

ID=23390270

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55165/90A Ceased AU636609B2 (en) 1989-05-18 1990-05-17 Dehydrocholecalciferol derivatives

Country Status (10)

Country Link
EP (1) EP0398217B1 (en)
JP (1) JPH0686381B2 (en)
AT (1) ATE99942T1 (en)
AU (1) AU636609B2 (en)
CA (1) CA2016985C (en)
DE (1) DE69005897D1 (en)
DK (1) DK0398217T3 (en)
IE (1) IE64186B1 (en)
NZ (1) NZ233704A (en)
ZA (1) ZA903758B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622139B2 (en) * 1988-01-20 1992-04-02 F. Hoffmann-La Roche Ag 16-dehydro-vitamin d3-derivatives
AU669222B2 (en) * 1992-11-20 1996-05-30 F. Hoffmann-La Roche Ag Vitamin D3 analogs
US5565442A (en) * 1992-09-18 1996-10-15 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
AU708679B2 (en) * 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
ATE237586T1 (en) * 1997-05-02 2003-05-15 Duphar Int Res METHOD FOR PRODUCING 16-DEHYDRO VITAMIN D COMPOUNDS
US9221753B2 (en) * 2004-02-03 2015-12-29 Chugai Seiyaku Kabushiki Kaisha Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
EP0215956A4 (en) * 1985-03-14 1988-09-07 Chugai Pharmaceutical Co Ltd Composition for treating skin disease.
US4898855A (en) * 1987-09-14 1990-02-06 Hoffman-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622139B2 (en) * 1988-01-20 1992-04-02 F. Hoffmann-La Roche Ag 16-dehydro-vitamin d3-derivatives
US5565442A (en) * 1992-09-18 1996-10-15 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3
US5804573A (en) * 1992-09-18 1998-09-08 Teva Pharmaceutical Industries Ltd. Stabilized pharmaceutical composition containing derivative of vitamins D2 and D3
AU669222B2 (en) * 1992-11-20 1996-05-30 F. Hoffmann-La Roche Ag Vitamin D3 analogs

Also Published As

Publication number Publication date
JPH0317019A (en) 1991-01-25
EP0398217A1 (en) 1990-11-22
EP0398217B1 (en) 1994-01-12
ZA903758B (en) 1992-01-29
DE69005897D1 (en) 1994-02-24
JPH0686381B2 (en) 1994-11-02
CA2016985C (en) 2001-03-27
IE901780L (en) 1990-11-18
NZ233704A (en) 1992-11-25
ATE99942T1 (en) 1994-01-15
IE64186B1 (en) 1995-07-12
CA2016985A1 (en) 1990-11-18
AU636609B2 (en) 1993-05-06
DK0398217T3 (en) 1994-02-14

Similar Documents

Publication Publication Date Title
MY100343A (en) Amide derivative and external medicament comprising same
FI870219A0 (en) HYPOGLYCHEMICAL THIAZOLIDINDIONER.
NO860424L (en) PROCEDURE FOR THE PREPARATION OF 6-THIOXANTHIN DERIVATIVES.
AU5516590A (en) Dehydrocholecalciferol derivatives
AU693283B2 (en) Acrylamide derivatives and process for producing the same
DE3662265D1 (en) Irreversible dopamine-b-hydroxylase inhibitors
AU640647B2 (en) 3-butenamide derivatives
DK7286D0 (en) OCTAHYDROINDOLIZINER
NZ219052A (en) Octahydroindolizine derivatives and pharmaceutical compositions
GR3003769T3 (en)
HUT71513A (en) 2-substituted-(3-chlorophenyl)-3,6-diazahexanoic acid derivatives for producing alkil-trazodone derivatives and process for producing them
AU557880B2 (en) Method for modulating the immune response with dibenzocycloheptenylidenes
ES8300747A1 (en) Indol acetic derivatives, process for producing the same and pharmaceutical compositions comprising the same.
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments
SU1744810A1 (en) Vasoactive agent "dimephosphone" normalizing vegetative nervous system functions